Access cutting-edge psoriatic arthritis treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access psoriatic arthritis specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related psoriatic arthritis treatment provided free
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The participants will be treated with either zasocitinib, or placebo. Participants will be in the study for up to 60 weeks.
Sponsor: Takeda
Check if you qualify for this psoriatic arthritis clinical trial in Tucson, AZ
If you're searching for psoriatic arthritis treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced psoriatic arthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.